128 related articles for article (PubMed ID: 11707965)
1. [Pharmacokinetic study of the intraperitoneal administration of CPT-11 for patients with peritoneal seedings of gastric and colonic cancers].
Maruyama M; Toukairin Y; Baba H; Kure N; Nagahama T; Ebuchi M
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1505-7. PubMed ID: 11707965
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetic study of CPT-11, SN-38 and SN-38 glucuronide in the ascites, plasma and bile after intraperitoneal administration of CPT-11].
Natsui S; Maruyama M; Ochiai T; Hasegawa K; Takashima I; Nagahama T; Ebuchi M
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2188-90. PubMed ID: 12484033
[TBL] [Abstract][Full Text] [Related]
3. [Experimental study on CPT-11 intraperitoneal chemotherapy--metabolism of CPT-11 in malignant ascites].
Maruyama M; Toukairin Y; Baba H; Yoshida T; Kure N; Nagahama T; Ebuchi M
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1858-60. PubMed ID: 11086430
[TBL] [Abstract][Full Text] [Related]
4. [Experimental study on intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis].
Maruyama M; Nagahama T; Ebuchi M; Yuasa Y
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1855-7. PubMed ID: 11086429
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of CPT-11 (irinotecan) in gastric cancer patients with peritoneal seeding after its intraperitoneal administration.
Ahn BJ; Choi MK; Park YS; Lee J; Park SH; Park JO; Lim HY; Kang WK; Ko JW; Yim DS
Eur J Clin Pharmacol; 2010 Dec; 66(12):1235-45. PubMed ID: 20827550
[TBL] [Abstract][Full Text] [Related]
6. [Experimental study on intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis].
Maruyama M; Ebuchi M; Nagahama T; Takashima I; Hasegawa K
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1602-4. PubMed ID: 14619474
[TBL] [Abstract][Full Text] [Related]
7. [Liver concentration of CPT-11, SN-38 and SN-38 GLU in intraperitoneal and intravenous administration of CPT-11].
Maruyama M; Nagahama T; Yuasa Y
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1967-9. PubMed ID: 10560438
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intraperitoneal irinotecan in a pig model.
Turcotte S; Sideris L; Younan R; Drolet P; Dubé P
J Surg Oncol; 2010 Jun; 101(7):637-42. PubMed ID: 20461774
[TBL] [Abstract][Full Text] [Related]
9. Phase I study of intraperitoneal irinotecan in patients with gastric adenocarcinoma with peritoneal seeding.
Choi MK; Ahn BJ; Yim DS; Park YS; Kim S; Sohn TS; Noh JH; Heo JS; Lee J; Park SH; Park JO; Lim HY; Kang WK
Cancer Chemother Pharmacol; 2011 Jan; 67(1):5-11. PubMed ID: 20213078
[TBL] [Abstract][Full Text] [Related]
10. [Intraperitoneal administration of CPT-11 in rats--experimental study for pharmacokinetics].
Nagahama T; Maruyama M; Goseki N
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1866-9. PubMed ID: 11086432
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis.
Maruyama M; Nagahama T; Yuasa Y
Anticancer Res; 1999; 19(5B):4187-91. PubMed ID: 10628373
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of SN-38-releasing polymeric micelles, NK012, on spontaneous peritoneal metastases from orthotopic gastric cancer in mice compared with irinotecan.
Nakajima TE; Yanagihara K; Takigahira M; Yasunaga M; Kato K; Hamaguchi T; Yamada Y; Shimada Y; Mihara K; Ochiya T; Matsumura Y
Cancer Res; 2008 Nov; 68(22):9318-22. PubMed ID: 19010905
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the pharmacokinetics and efficacy of irinotecan after administration by the intravenous versus intraperitoneal route in mice.
Guichard S; Chatelut E; Lochon I; Bugat R; Mahjoubi M; Canal P
Cancer Chemother Pharmacol; 1998; 42(2):165-70. PubMed ID: 9654118
[TBL] [Abstract][Full Text] [Related]
14. [A case of gastric cancer with peritoneal dissemination which shows a remarkable efficacy by a weekly administration of paclitaxel intraperitoneally].
Kato K; Koide A; Oobu M; Hasegawa K; Maruyama S; Takashima I; Nagahama T; Maruyama M; Ebuchi M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1852-4. PubMed ID: 15553737
[TBL] [Abstract][Full Text] [Related]
15. [Safety of intraperitoneal chemotherapy with paclitaxel in gastric cancer patients with peritoneal dissemination].
Fujitani K; Hirao M; Tsujinaka T
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1855-7. PubMed ID: 15553738
[TBL] [Abstract][Full Text] [Related]
16. [A case of peritoneal dissemination disappeared by CPT-11 + TS-1 combination chemotherapy].
Takemoto H; Fukunaga M; Ooshiro R; Fujishima M; Yamamoto K; Tanaka J; Kondo M; Kishimoto T; Nakayama T; Imamura H; Masutani S; Tatsuta M; Kawasaki T; Furukawa H
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1768-70. PubMed ID: 16315935
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacologic study of intraperitoneal docetaxel in gastric cancer patients with peritoneal dissemination].
Fushida S; Nao F; Kinami S; Ninomiya I; Fujimura T; Nishimura G; Ohta T; Yokogawa K; Miyamoto K; Miwa K
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1759-63. PubMed ID: 12402426
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of prolonged-release CPT-11-loaded microspheres in rats.
Machida Y; Onishi H; Kurita A; Hata H; Morikawa A; Machida Y
J Control Release; 2000 May; 66(2-3):159-75. PubMed ID: 10742577
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal versus intravenous CPT-11 given intra- and postoperatively for peritoneal carcinomatosis in a rat model.
Hribaschek A; Kuhn R; Pross M; Meyer F; Fahlke J; Ridwelski K; Boltze C; Lippert H
Surg Today; 2006; 36(1):57-62. PubMed ID: 16378195
[TBL] [Abstract][Full Text] [Related]
20. [A patient with peritoneal metastasis from gastric cancer who responded to weekly chemotherapy with paclitaxel on the third line and could take meal].
Nakae S; Urakawa T; Yamamoto M; Kinoshita H; Sainoh K; Kitaura T; Takahashi T; Takao S; Shiroiwa H; Onoyama H; Sugihara S; Toyota J; Saitoh Y
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1161-4. PubMed ID: 12938274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
